Clene Inc CLNN 深 沪

Clene Q1 GAAP每股亏损0.69美元，营收仅1万美元

　　临床阶段生物制药公司Clene周四公布2026年第一季度财报。公司GAAP每股亏损0.69美元，营收仅1万美元，远低于市场预期。不过，公司在ALS药物CN...

05-14 22:45

Clene Q1 EPS $(0.69) Misses $(0.66) Estimate, Sales $15.000K Miss $35.064K Estimate

Clene (NASDAQ:CLNN) reported quarterly losses of $(0.69) per share which missed the analyst consensus estimate of $(0.66) by 4.55 percent. This is a 666.67 percent decrease over losses of $(0.09) per share from the same

05-14 20:39

Transcript: Enlight Renewable Energy Q1 2026 Earnings Conference Call

Enlight Renewable Energy (NASDAQ:ENLT) released first-quarter financial results...

05-05 21:09

Clene prices $7M registered direct offering

Clene (CLNN) and its wholly owned subsidiary, Clene Nanomedicine on Tuesday announced the pricing of an underwritten registered direct offering of 1M shares of common stock at a purchase price of $7.0...

05-05 21:03

美股大行评级 | 潜在涨幅85%！SoFi获机构升目标价至49美元；华尔街大行看涨AMD至400美元

今日重点评级关注：Canaccord Genuity：维持Sagimet Biosciences"买入"评级，目标价从28美元升至49美元；HC Wainwright & Co.：维持Fate Therapeutics"买入"评级，目标价从5美元升至7美元

05-05 11:40

Clene Advances CNM-Au8 Toward Accelerated ALS Approval

An announcement from Clene ( ($CLNN) ) is now available. On May 4, 2026, Clene ...

05-04 20:33

Clene Announces FDA Approves Propose Data To Be Capable for Submission, Review Of New Drug Application For Pathway To Treat Amyotrophic Lateral Sclerosis

Clene Inc. (NASDAQ:CLNN) (along with its subsidiaries, "Clene") and its wholly owned subsidiary Clene Nanomedicine Inc., a late clinical-stage biopharmaceutical company focused on revolutionizing the treatment of

05-04 20:09

After Successful FDA Meeting, Clene Filing Accelerated Approval NDA for ALS

05-04 12:00

Clene, Lovesac, HDFC Bank, State Street, Vor Shock

Insiders have been trading these 5 stocks: (($CLNN)), (($LOVE)), (($HDB)), (($S...

04-25 21:01

Surf Air, Cytokinetics, ASE, Itau, Clene Insider Shake-Up

Insiders have been trading these 5 stocks: (($SRFM)), (($CYTK)), (($ASX)), (($I...

04-18 21:01